|
1
|
De Mello WC: Novel aspects of angiotensin
II action in the heart. Implications to myocardial ischemia and
heart failure. Regul Pept. 166:9–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ainscough JF, Drinkhill MJ, Sedo A, Turner
NA, Brooke DA, Balmforth AJ and Ball SG: Angiotensin II type-1
receptor activation in the adult heart causes blood
pressure-independent hypertrophy and cardiac dysfunction.
Cardiovasc Res. 81:592–600. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dang MQ, Zhao XC, Lai S, Wang X, Wang L,
Zhang YL, Liu Y, Yu XH, Liu Y, Li HH and Xia YL: Gene expression
profile in the early stage of angiotensin II-induced cardiac
remodeling: A time series microarray study in a mouse model. Cell
Physiol Biochem. 35:467–476. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang J, Zhu HH, Chen GP, Ye Y, Zhao CZ,
Mou Y and Hu SJ: Inhibition of farnesyl pyrophosphate synthase
attenuates angiotensin II-induced cardiac hypertrophy and fibrosis
in vivo. Int J Biochem Cell Biol. 45:657–666. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan SH and Chan JY: (Pro)renin receptor
as a therapeutic target for the treatment of hypertension?
Hypertension. 65:278–279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oshima Y, Morimoto S and Ichihara A: Roles
of the (pro)renin receptor in the kidney. World J Nephrol.
3:302–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gonzalez AA, Luffman C, Bourgeois CR, Vio
CP and Prieto MC: Angiotensin II-independent upregulation of
cyclooxygenase-2 by activation of the (Pro)renin receptor in rat
renal inner medullary cells. Hypertension. 61:443–449. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burcklé CA, Jan Danser AH, Müller DN,
Garrelds IM, Gasc JM, Popova E, Plehm R, Peters J, Bader M and
Nguyen G: Elevated blood pressure and heart rate in human renin
receptor transgenic rats. Hypertension. 47:552–556. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Danser AH: (Pro)renin receptors: Are they
biologically relevant? Curr Opin Nephrol Hypertens. 18:74–78. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaneshiro Y, Ichihara A, Sakoda M,
Takemitsu T, Nabi AH, Uddin MN, Nakagawa T, Nishiyama A, Suzuki F,
Inagami T and Itoh H: Slowly progressive, angiotensin
II-independent glomerulosclerosis in human (pro)renin
receptor-transgenic rats. J Am Soc Nephrol. 18:1789–1795. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alcazar O, Cousins SW, Striker GE and
Marin-Castano ME: (Pro)renin receptor is expressed in human retinal
pigment epithelium and participates in extracellular matrix
remodeling. Exp Eye Res. 89:638–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakoda M, Ichihara A, Kaneshiro Y,
Takemitsu T, Nakazato Y, Nabi AH, Nakagawa T, Suzuki F, Inagami T
and Itoh H: (Pro)renin receptor-mediated activation of
mitogen-activated protein kinases in human vascular smooth muscle
cells. Hypertens Res. 30:1139–1146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ichihara A, Kaneshiro Y, Takemitsu T,
Sakoda M, Suzuki F, Nakagawa T, Nishiyama A, Inagami T and Hayashi
M: Nonproteolytic activation of prorenin contributesto development
of cardiac fibrosis in genetic hypertension. Hypertension.
47:894–900. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feldt S, Maschke U, Dechend R, Luft FC and
Muller DN: The putative (pro)renin receptor blocker HRP fails to
prevent (pro)renin signaling. J Am Soc Nephrol. 19:743–748. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu X, Danser AH and Meima ME: HRP and
prorenin: Focus on the (pro)renin receptor and vacuolar H+-ATPase.
Front Biosci (Schol Ed). 3:1205–1215. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Li B, Wang B, Zhang J, Wu J and
Morgan T: Alteration of cardiac ACE2/Mas expression and cardiac
remodelling in rats with aortic constriction. Chin J Physiol.
57:335–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Ma L, Wu J and Chen T:
Hydronephrosis alters cardiac ACE2 and Mas receptor expression in
mice. J Renin Angiotensin Aldosterone Syst. 16:267–274. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Wu J, Zhang Z, Wang B, Chen P and
Jing X: Effect of low sodium intake and β-blockade on renin
synthesis and secretion in mice with unilateral ureteral ligation.
Hypertens Res. 33:1258–1263. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Connelly KA, Advani A, Kim S, Advani SL,
Zhang M, White KE, Kim YM, Parker C, Thai K, Krum H, et al: The
cardiac (pro)renin receptor is primarily expressed in myocyte
transverse tubules and is increased in experimental diabetic
cardiomyopathy. J Hypertens. 29:1175–1184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hirose T, Mori N, Totsune K, Morimoto R,
Maejima T, Kawamura T, Metoki H, Asayama K, Kikuya M, Ohkubo T, et
al: Gene expression of (pro)renin receptor is upregulated in hearts
and kidneys of rats with congestive heart failure. Peptides.
30:2316–2322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nguyen G, Delarue F, Burcklé C, Bouzhir L,
Giller T and Sraer JD: Pivotal role of the renin/prorenin receptor
in angiotensin II production and cellular responses to renin. J
Clin Invest. 109:1417–1427. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saris JJ, Hoen PA, Garrelds IM, Dekkers
DH, den Dunnen JT, Lamers JM and Jan Danser AH: Prorenin induces
intracellular signaling in cardiomyocytes independently of
angiotensin II. Hypertension. 48:564–571. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cousin C, Bracquart D, Contrepas A and
Nguyen G: Potential role of the (pro)renin receptor in
cardiovascular and kidney diseases. J Nephrol. 23:508–513.
2010.PubMed/NCBI
|
|
24
|
Nguyen G and Muller DN: The biology of the
(pro)renin receptor. J Am Soc Nephrol. 21:18–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Makary S, Voigt N, Maguy A, Wakili R,
Nishida K, Harada M, Dobrev D and Nattel S: Differential protein
kinase C isoform regulation and increased constitutive activity of
acetylcholine-regulated potassium channels in atrial remodeling.
Circ Res. 109:1031–1043. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Otani H, Yoshioka K, Nishikawa H, Inagaki
C and Nakamura T: Involvement of protein kinase C and RhoA in
protease-activated receptor 1-mediated F-actin reorganization and
cell growth in rat cardiomyocytes. J Pharmacol Sci. 115:135–143.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Palfi A, Bartha E, Copf L, Mark L, Gallyas
F Jr, Veres B, Kalman E, Pajor L, Toth K, Ohmacht R and Sumegi B:
Alcohol-free red wine inhibits isoproterenol-induced cardiac
remodeling in rats by the regulation of Akt1 and protein kinase C
alpha/beta II. J Nutr Biochem. 20:418–425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Atef ME and Anand-Srivastava MB: Enhanced
expression of Gqα and PLC-β1 proteins contributes to vascular
smooth muscle cell hypertrophy in SHR: Role of endogenous
angiotensin II and endothelin-1. Am J Physiol Cell Physiol.
307:C97–C106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang L, Malik S, Pang J, Wang H, Park KM,
Yule DI, Blaxall BC and Smrcka AV: Phospholipase Cε hydrolyzes
perinuclear phosphatidylinositol 4-phosphate to regulate cardiac
hypertrophy. Cell. 153:216–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woodcock EA, Grubb DR and Iliades P:
Potential treatment of cardiac hypertrophy and heart failure by
inhibiting the sarcolemmal binding of phospholipase Cbeta1b. Curr
Drug Targets. 11:1032–1040. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singal T, Dhalla NS and Tappia PS:
Regulation of c-Fos and c-Jun gene expression by phospholipase C
activity in adult cardiomyocytes. Mol Cell Biochem. 327:229–239.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singal T, Dhalla NS and Tappia PS:
Reciprocal regulation of transcription factors and PLC isozyme gene
expression in adult cardiomyocytes. J Cell Mol Med. 14:1824–1835.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schnabel P, Mies F, Nohr T, Geisler M and
Böhm M: Differential regulation of phospholipase C-beta isozymes in
cardiomyocyte hypertrophy. Biochem Biophys Res Commun. 275:1–6.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bai H, Wu LL, Xing DQ, Liu J and Zhao YL:
Angiotensin II upregulation of G alpha q/11, phospholipase C beta 3
and extracellular signal-regulated kinase 1/2 via angiotensin II
type 1 receptor. Chin Med J (Engl). 117:88–93. 2004.PubMed/NCBI
|
